Evaluation of Omentopexy on Gastro-oesophageal Reflux Following Sleeve Gastrectomy (Sleevepexie)

  • End date
    Nov 1, 2026
  • participants needed
  • sponsor
    Centre Hospitalier Departemental Vendee
Updated on 21 March 2022
sleeve gastrectomy


The aim of the study is to assess impact of omentopexy on de novo gastro-oesophageal reflux disease (GERD) after sleeve gastrectomy.

This will be assess 2 years postoperatively. This study is a prospective, multicentric, randomized trial. Five hundred twenty six patients should be included with 263 in each arm. First arm will include patients who have a sleeve gastrectomy. The second arm will include patients who have sleeve gastrectomy with omentopexy.

Two years after surgery , it will be collected a CARLSSON score and BAROS score (quality of life).

The main objective is to show that omentopexy decreases the rate of de novo GERD after sleeve gastrectomy at 2 years postoperatively without the use of Proton-Pump Inhibitors (PPIs)

Condition Obesity
Treatment sleeve gastrectomy, sleeve gastrectomy with omentopexy
Clinical Study IdentifierNCT04994665
SponsorCentre Hospitalier Departemental Vendee
Last Modified on21 March 2022


Yes No Not Sure

Inclusion Criteria

Patient ≥ 18 years old
Patient to be operated in first intention of a sleeve gastrectomy
Initial BMI between 35Kg/m² and 40 Kg/m² associated with an obesity-related comorbidity (hypertension, obstructive sleep apnea syndrome, type II diabetes, early osteoarthritis authenticated by a rheumatologist or an orthopedist, dyslipidemia, hepatic steatosis) OR initial BMI ≥ 40 Kg/m²
Multidisciplinary follow-up of at least 6 months before surgery
Validation of the surgical intervention in a multidisciplinary consultation meeting
Certificate of no contraindication by a psychiatrist
Patient who has the capacity to understand the protocol and has given consent to participate in the research
Patient with social security coverage

Exclusion Criteria

Eating disorder or mental disorder
Misunderstanding of the protocol
Psychiatric contraindication
Initial BMI <35Kg/m²
Initial BMI between 35Kg/m² and 40 Kg/m² without comorbidities
Esophagitis of grade B and above on the Oeso-Gastro-Duodenal Fibroscopy
CARLSSON score (score ≥ 4) preoperatively
Presence of a Proton-Pump Inhibitors treatment
Patient to have a 2-stage surgery (first sleeve gastrectomy then gastric bypass or Single Anastomosis Duodeno-Ileal bypass)
Patient participating in another interventional clinical research protocol involving a drug or medical device
Patient who are pregnant, breastfeeding, or who have the potential to become pregnant without effective contraception at the time of inclusion and up to 24 months after surgery
Patient under guardianship, curators or legal protection,P
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note